{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:40:30Z","timestamp":1791812430607,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019 M661035"],"award-info":[{"award-number":["2019 M661035"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000085","name":"Directorate for Geosciences","doi-asserted-by":"publisher","award":["GSE19234"],"award-info":[{"award-number":["GSE19234"]}],"id":[{"id":"10.13039\/100000085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000085","name":"Directorate for Geosciences","doi-asserted-by":"publisher","award":["GSE22153"],"award-info":[{"award-number":["GSE22153"]}],"id":[{"id":"10.13039\/100000085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000085","name":"Directorate for Geosciences","doi-asserted-by":"publisher","award":["GSE53118"],"award-info":[{"award-number":["GSE53118"]}],"id":[{"id":"10.13039\/100000085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.intimp.2020.106887","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T17:50:05Z","timestamp":1597254605000},"page":"106887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma"],"prefix":"10.1016","volume":"88","author":[{"given":"Xinhua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2020.106887_b0005","doi-asserted-by":"crossref","first-page":"330e","DOI":"10.1097\/PRS.0000000000002367","article-title":"Malignant Melanoma: Beyond the Basics","volume":"138","author":"Pavri","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.intimp.2020.106887_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-319-22539-5_4","article-title":"Melanoma: Clinical Presentations","volume":"167","author":"Kibbi","year":"2016","journal-title":"Cancer Treat. Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.106887_b0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.det.2012.04.007","article-title":"The pathology of melanoma","volume":"30","author":"Cockerell","year":"2012","journal-title":"Dermatol. Clin."},{"issue":"3","key":"10.1016\/j.intimp.2020.106887_b0020","doi-asserted-by":"crossref","first-page":"37e","DOI":"10.1097\/PRS.0b013e318206352b","article-title":"Cutaneous malignancies: melanoma and nonmelanoma types","volume":"127","author":"Netscher","year":"2011","journal-title":"Plast. Reconstr. Surg."},{"issue":"23","key":"10.1016\/j.intimp.2020.106887_b0025","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1002\/cncr.29634","article-title":"Revisiting determinants of prognosis in cutaneous melanoma","volume":"121","author":"Weiss","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2020.106887_b0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","article-title":"Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers","volume":"36","author":"Abbas","year":"2014","journal-title":"American J. Dermatopathol."},{"issue":"13","key":"10.1016\/j.intimp.2020.106887_b0035","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-015-1880-8","article-title":"Structure and function insights into the NuRD chromatin remodeling complex","volume":"72","author":"Torchy","year":"2015","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"10.1016\/j.intimp.2020.106887_b0040","unstructured":"D. Lin, An information-theoretic definition of similarity, international conference on machine learning (1998) 296-304."},{"issue":"1","key":"10.1016\/j.intimp.2020.106887_b0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molcel.2018.06.003","article-title":"The Nucleosome Remodeling and Deacetylation Complex Modulates Chromatin Structure at Sites of Active Transcription to Fine-Tune Gene Expression","volume":"71","author":"Bornelov","year":"2018","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.intimp.2020.106887_b0050","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.jmb.2016.04.025","article-title":"The Nucleosome Remodeling and Deacetylase Complex NuRD Is Built from Preformed Catalytically Active Sub-modules","volume":"428","author":"Zhang","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106887_b0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1097-2765(00)80299-3","article-title":"NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities","volume":"2","author":"Xue","year":"1998","journal-title":"Mol. Cell"},{"issue":"15\u201316","key":"10.1016\/j.intimp.2020.106887_b0060","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1101\/gad.326066.119","article-title":"Dangerous liaisons: interplay between SWI\/SNF NuRD, and Polycomb in chromatin regulation and cancer","volume":"33","author":"Bracken","year":"2019","journal-title":"Genes Development"},{"issue":"4","key":"10.1016\/j.intimp.2020.106887_b0065","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cell.2009.05.050","article-title":"LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.intimp.2020.106887_b0070","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1158\/0008-5472.CAN-19-1034","article-title":"MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells","volume":"79","author":"Hata","year":"2019","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2020.106887_b0075","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng.2455","article-title":"Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes","volume":"44","author":"Le Gallo","year":"2012","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.intimp.2020.106887_b0080","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.1222577110","article-title":"Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma","volume":"110","author":"Zhao","year":"2013","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.intimp.2020.106887_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090810","article-title":"Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS ONE"},{"issue":"47","key":"10.1016\/j.intimp.2020.106887_b0090","doi-asserted-by":"crossref","first-page":"83155","DOI":"10.18632\/oncotarget.17950","article-title":"HDAC inhibitors enhance the immunotherapy response of melanoma cells","volume":"8","author":"Booth","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.intimp.2020.106887_b0095","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","article-title":"Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance","volume":"76","author":"Krumm","year":"2016","journal-title":"Cancer Res."},{"issue":"48","key":"10.1016\/j.intimp.2020.106887_b0100","doi-asserted-by":"crossref","first-page":"20429","DOI":"10.1073\/pnas.0905139106","article-title":"Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival","volume":"106","author":"Bogunovic","year":"2009","journal-title":"PNAS"},{"issue":"13","key":"10.1016\/j.intimp.2020.106887_b0105","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-09-2509","article-title":"Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome","volume":"16","author":"Jonsson","year":"2010","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"2","key":"10.1016\/j.intimp.2020.106887_b0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/jid.2012.283","article-title":"BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma","volume":"133","author":"Mann","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106887_b0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2014.05.003","article-title":"The nucleosome remodeling and deacetylase complex in development and disease","volume":"165","author":"Basta","year":"2015","journal-title":"Translational research : the journal of laboratory and clinical medicine"},{"key":"10.1016\/j.intimp.2020.106887_b0120","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.561","article-title":"Removing batch effects for prediction problems with frozen surrogate variable analysis","volume":"2","author":"Parker","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2020.106887_b0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"19","key":"10.1016\/j.intimp.2020.106887_b0130","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","article-title":"GenVisR: Genomic Visualizations in R","volume":"32","author":"Skidmore","year":"2016","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.intimp.2020.106887_b0135","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2020.106887_b0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fmed.2020.00064","article-title":"Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database","volume":"7","author":"Xu","year":"2020","journal-title":"Frontiers in medicine"},{"key":"10.1016\/j.intimp.2020.106887_b0145","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8128","article-title":"Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma","volume":"7","author":"Yue","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2020.106887_b0150","doi-asserted-by":"crossref","unstructured":"J.E. Lang, J.H. Scott, D.M. Wolf, P. Novak, V. Punj, M.J. Magbanua, W. Zhu, N. Mineyev, C.M. Haqq, J.R. Crothers, L.J. Esserman, D. Tripathy, L. van 't Veer, J.W. Park, Expression profiling of circulating tumor cells in metastatic breast cancer, Breast cancer research and treatment 149(1) (2015) 121-31.","DOI":"10.1007\/s10549-014-3215-0"},{"issue":"9","key":"10.1016\/j.intimp.2020.106887_b0155","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41591-018-0134-3","article-title":"Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab","volume":"24","author":"Gandara","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2020.106887_b0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"8","key":"10.1016\/j.intimp.2020.106887_b0165","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jtho.2018.04.003","article-title":"Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report","volume":"13","author":"Owada-Ozaki","year":"2018","journal-title":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer"},{"issue":"23","key":"10.1016\/j.intimp.2020.106887_b0170","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","article-title":"GSEA-P: a desktop application for Gene Set Enrichment Analysis","volume":"23","author":"Subramanian","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2020.106887_b0175","doi-asserted-by":"crossref","unstructured":"C. Franklin, E. Livingstone, A. Roesch, B. Schilling, D. Schadendorf, Immunotherapy in melanoma: Recent advances and future directions, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 43(3) (2017) 604-611.","DOI":"10.1016\/j.ejso.2016.07.145"},{"issue":"5","key":"10.1016\/j.intimp.2020.106887_b0180","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2016.09.010","article-title":"FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis","volume":"30","author":"Shan","year":"2016","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.intimp.2020.106887_b0185","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41422-018-0079-6","article-title":"Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR\/PI3K\/AKT drives breast carcinogenesis","volume":"28","author":"He","year":"2018","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.106887_b0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13148-020-00827-3","article-title":"CHD4\/NuRD complex regulates complement gene expression and correlates with CD8 T cell infiltration in human hepatocellular carcinoma","volume":"12","author":"Shao","year":"2020","journal-title":"Clinical epigenetics"},{"issue":"1","key":"10.1016\/j.intimp.2020.106887_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-13-0196","article-title":"Eosinophils and cancer","volume":"2","author":"Davis","year":"2014","journal-title":"Cancer immunology research"},{"issue":"5","key":"10.1016\/j.intimp.2020.106887_b0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00262-018-2255-4","article-title":"Opposing roles of eosinophils in cancer","volume":"68","author":"Simon","year":"2019","journal-title":"Cancer immunology, immunotherapy : CII"},{"issue":"7","key":"10.1016\/j.intimp.2020.106887_b0205","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2174\/0929867323666160119094313","article-title":"Eosinophils in Cancer: Favourable or Unfavourable?","volume":"23","author":"Sakkal","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2020.106887_b0210","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/ajco.12871","article-title":"The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage - colorectal cancer","volume":"14","author":"Wei","year":"2018","journal-title":"Asia-Pacific journal of clinical oncology"},{"issue":"3","key":"10.1016\/j.intimp.2020.106887_b0215","first-page":"807","article-title":"Eosinophils and human cancer","volume":"12","author":"Samoszuk","year":"1997","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106887_b0220","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1186\/s12885-018-5131-x","article-title":"New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer","volume":"18","author":"Holub","year":"2018","journal-title":"BMC cancer"},{"key":"10.1016\/j.intimp.2020.106887_b0225","doi-asserted-by":"crossref","unstructured":"G. Deepthi, P.G. Kulkarni, K.N. SR, Eosinophils: An imperative histopathological prognostic indicator for oral squamous cell carcinoma, Journal of oral and maxillofacial pathology : JOMFP 23(2) (2019) 307.","DOI":"10.4103\/jomfp.JOMFP_111_19"},{"key":"10.1016\/j.intimp.2020.106887_b0230","first-page":"2908","volume":"22","author":"Martens","year":"2016","journal-title":"Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab, Clinical cancer research : an official journal of"},{"issue":"22","key":"10.1016\/j.intimp.2020.106887_b0235","first-page":"5487","article-title":"Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab, Clinical cancer research : an official journal of the American Association for","volume":"22","author":"Weide","year":"2016","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.106887_b0240","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/cam4.878","article-title":"The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma","volume":"5","author":"Khoja","year":"2016","journal-title":"Cancer medicine"},{"issue":"4","key":"10.1016\/j.intimp.2020.106887_b0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11523-018-0565-2","article-title":"The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma","volume":"13","author":"Liu","year":"2018","journal-title":"Targeted oncology"},{"key":"10.1016\/j.intimp.2020.106887_b0250","first-page":"564","article-title":"Frontline Therapy for BRAF-Mutated Metastatic Melanoma: How Do You Choose, and Is There One Correct Answer?, American Society of Clinical Oncology educational book","volume":"39","author":"Pavlick","year":"2019","journal-title":"American Society of Clinical Oncology. Annual Meeting"},{"issue":"6","key":"10.1016\/j.intimp.2020.106887_b0255","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41591-019-0476-5","article-title":"Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","volume":"25","author":"Ribas","year":"2019","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2020.106887_b0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"279","key":"10.1016\/j.intimp.2020.106887_b0265","doi-asserted-by":"crossref","first-page":"279ra41","DOI":"10.1126\/scitranslmed.aaa4691","article-title":"Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma","volume":"7","author":"Hu-Lieskovan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2020.106887_b0270","doi-asserted-by":"crossref","unstructured":"W. Guo, L. Zhu, R. Zhu, Q. Chen, Q. Wang, J.Q. Chen, A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma, eLife 8 (2019).","DOI":"10.7554\/eLife.44310"},{"issue":"10","key":"10.1016\/j.intimp.2020.106887_b0275","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.7150\/jca.30612","article-title":"The prognostic value of the proteasome activator subunit gene family in skin cutaneous melanoma","volume":"10","author":"Wang","year":"2019","journal-title":"Journal of Cancer"},{"key":"10.1016\/j.intimp.2020.106887_b0280","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7831","article-title":"Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients","volume":"7","author":"Lu","year":"2019","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.intimp.2020.106887_b0285","first-page":"1178","article-title":"A six-long non-coding RNA signature predicts prognosis in melanoma patients","volume":"52","author":"Yang","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106887_b0290","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jdermsci.2016.12.006","article-title":"Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments","volume":"85","author":"Chen","year":"2017","journal-title":"J. Dermatol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920322487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920322487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T22:42:10Z","timestamp":1744497730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920322487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":58,"alternative-id":["S1567576920322487"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106887","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106887"}}